Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin

被引：4

作者：

Suzuki, Yasuhito ^{[1
]}

Tanino, Yoshinori ^{[1
]}

Nikaido, Takefumi ^{[1
]}

Minemura, Hiroyuki ^{[1
]}

Umeda, Takashi ^{[1
]}

Rikimaru, Mami ^{[1
]}

Onuma, Takumi ^{[1
]}

Naito, Shotaro ^{[2
]}

Takiguchi, Yoshinori ^{[3
]}

Tomita, Hikaru ^{[1
]}

Kawamata, Takaya ^{[1
]}

Togawa, Ryuichi ^{[1
]}

Sato, Yuki ^{[1
]}

Uematsu, Manabu ^{[1
]}

Morimoto, Julia ^{[1
]}

Kitakawa, Kadzuhiro ^{[4
]}

Tsukada, Yasuhiko ^{[5
]}

Nakamura, Kiwamu ^{[6
]}

Kanemitsu, Keiji ^{[6
]}

Iseki, Ken ^{[5
]}

Shibata, Yoko ^{[1
]}

机构：

[1] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Japan

[2] Fukushima Med Univ, Dept Gen Internal Med, Fukushima, Japan

[3] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, Fukushima, Japan

[4] Fukushima Prefectural Inst Publ Hlth, Fukushima, Japan

[5] Fukushima Med Univ, Dept Emergency & Crit Care Med, Fukushima, Japan

[6] Fukushima Med Univ, Dept Infect Control, Fukushima, Japan

来源：

INTERNAL MEDICINE | 2021年 / 60卷 / 03期

关键词：

coronavirus disease 2019; COVID-19; intravenous immunoglobulin; severe acute respiratory syndrome-coronavirus-2; acute respiratory distress syndrome; deterioration; COVID-19; MODULATE;

D O I：

10.2169/internalmedicine.6326-20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report a case of severe coronavirus disease 2019 (COVID-19) in which high-dose intravenous immunoglobulin (IVIg) treatment achieved significant clinical improvement of deterioration of pulmonary inflammation after temporary clinical improvement. In the present case, clinical and radiological deterioration occurred despite a decrease in viral load, suggesting that deterioration was caused by reactivation of proinflammatory factors. such as tumor necrosis factor-a and interleukin-6, rather than direct viral effects. IVIg treatment may provide not only immunosuppressive effects but also inhibition of proinflammatory cytoldnes, indicating that treatment including IVIg may be effective by inhibiting cytokine storm in severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection.

引用

页码：457 / 461

页数：5

共 50 条

[21] High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
Suzuki, Takanori
Michihata, Nobuaki
Yoshikawa, Tetsushi
Hata, Tadayoshi
Matsui, Hiroki
Fushimi, Kiyohide
Yasunaga, Hideo
EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (12) : 1901 - 1907
[22] High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
Takanori Suzuki
Nobuaki Michihata
Tetsushi Yoshikawa
Tadayoshi Hata
Hiroki Matsui
Kiyohide Fushimi
Hideo Yasunaga
European Journal of Pediatrics, 2020, 179 : 1901 - 1907
[23] Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin
Whitington, Peter F.
Kelly, Susan
PEDIATRICS, 2008, 121 (06) : E1615 - E1621
[24] High-dose Intravenous Immunoglobulin Therapy for Systemic Capillary Leak Syndrome (Clarkson Disease)
Xie, Zhihui
Chan, Eunice C.
Long, Lauren M.
Nelson, Celeste
Druey, Kirk M.
AMERICAN JOURNAL OF MEDICINE, 2015, 128 (01) : 91 - 95
[25] High-dose intravenous immunoglobulin treatment and cerebral vasospasm: A possible mechanism of ischemic encephalopathy?
Sztajzel, R
Le Floch-Rohr, J
Eggimann, P
EUROPEAN NEUROLOGY, 1999, 41 (03) : 153 - 158
[26] Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease
Lee, KY
Han, JW
Lee, JS
Whang, KT
ACTA PAEDIATRICA, 2002, 91 (02) : 164 - 167
[27] Mechanical circulatory support in coronavirus disease-2019-positive patients with severe respiratory failure
Natanov, Ruslan
Wiesner, Olaf
Haverich, Axel
Kuehn, Christian
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 33 (03) : 489 - 493
[28] Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression
Cohen, Myron S.
Wohl, David A.
Fischer, William A., II
Smith, Davey M.
Eron, Joseph J.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : 1717 - 1721
[29] Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study
Aggarwal, Ritesh
Dewan, Arun
Pandey, Ankita
Trehan, Nikita
Majid, Muhammad Aamir
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 106
[30] High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Liu, Xiaosheng
Cao, Wei
Li, Taisheng
FRONTIERS IN IMMUNOLOGY, 2020, 11

← 1 2 3 4 5 →